FDES after experimental cerebral ischemia
V. Ts. Bolotova, I. A. Titovich, E. B. Shustov · 2021 · Journal Biomed. 2021;17(3):100–104
Reported findings and study design
An animal neuroprotection lead.
| Measure | Result | Comparison, timing and statistics |
|---|---|---|
| Sensorimotor and tissue outcomes | The authors report improvement in selected sensorimotor measures and a reduction in cortical injury volume. |
The abstract cannot establish clinical stroke efficacy or equivalence to citicoline.
Source for the extracted data ↗ · Checked 2026-11-06
Molekul summary of the linked publication. Educational information, not medical advice. Seek qualified healthcare help for medical conditions.
Methods, limitations & source review
Study limitations
- Allocation, animal counts and full adverse findings require the original paper.
- The abstract’s comparison with citicoline is not an equivalence trial or evidence of human stroke benefit.
Publication counts are not counts of independent trials. Reviews, translations and reports sharing participants may overlap. Findings apply to the studied preparation, population and endpoints.
Document format: Publisher-deposited Crossref abstract
Review depth: Abstract only
Source access and review scope
Publisher-deposited abstract; original tables not recovered.
Recorded source-check date: 2026-11-06. This date does not imply a completed systematic review.
Source type: Original animal research
Citation and original source
Original source: V. Ts. Bolotova, I. A. Titovich, E. B. Shustov. FDES after experimental cerebral ischemia Journal Biomed. 2021;17(3):100–104 2021.
Molekul research summary: https://molekul.io/research/shustov-fdes-neuroprotection-2021. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.
Bibliography entry